Vietnam’s COVID-19 Nanocovax vaccine to be priced US $10.3 per dose
	In video: View into Vietnam's COVID-19 vaccine manufacturing factory
	Vietnam’s COVID-19 vaccine to be priced under US $22

Covivac will become the second COVID-19 vaccine made in Vietnam to enter human trials (Photo: VOV)

Covivac - Vietnam's potential COVID-19 vaccine candidate

The Covivac vaccine is the research work of the Institute of Vaccines and Medical Biologicals (IVAC) under the Ministry of Health (MOH). It had earlier yielded safe results and a strong immunity responses on mice, rabbits, etc. Given promising results on animals, the vaccine is granted to enter human trials starting January, two months earlier than expected.

As reported by VOV, IVAC will cooperate with the National Institute of Hygiene and Epidemiology and Hanoi Medical University to trial the vaccine on 125 volunteers aged 18-59. Those receiving IVAC’s trial jabs must be healthy, having no underlying disease and satisfying several other specific criteria.

Covivac vaccine (Photo: VOV)

The first batch of volunteers will be divided into different groups who receive different doses. Following stages will be conducted if the human trials go smoothly.

According to Dr. Duong Huu Thai, Director of IVAC, the Institue has been studying Covivac since last May, aiming at successfully producing the vaccine and completing three human trials within 18 months. The first phase of the trails is scheduled to finish in April.

“If all three trial phases yield good results, Vietnam might have the vaccine in late 2021”, Thai said. “IVAC has an edge in the production process thanks to its available infrastructure, technology, and decade-long experience in producing flu vaccines”.

About Nanocovax caccine

Earlier on December 10, Nanogen’s COVID-19 vaccine was the first of its kind indigenous in Vietnam to enter human trials. Nanogen Biopharmaceutical company is expected to end its Nanocovax vaccine’s human trials by February 2022.

The human clinical trials protocol, which includes three phrases, was approved by the Ethics Council of the Ministry of Health on December 9.

Each phrase consists of two injections, 28 days apart.

The first phase aiming at testing the safety of Nanocovax started on December 10 and is scheduled to end in February 2021. It was conducted in Hanoi on 60 volunteers aged 18-50. The first three volunteers who received the jab on December 17 showed no abnormal symptoms to date.

The second phase is planned to start right after the first one and last for 6 months. 400-600 volunteers aged 12-75 will be recruited for the trial, which evaluates the immunogenicity and preventive potency of the vaccine.

The third phase (August 2021 - February 2022) is planned to take place in an epidemiological area in India, Indonesia, or Bangladesh to gather enough 1,500 – 3,000 volunteers aged 12-75.

Researchers said they might kick off the second phase earlier right after the first phase yields 50 percent effective. Thus, according to Do Minh Si, Development Research Director of Nanogen, the clinical trials might end at the end of 2021.

Nanocovax is priced at VND120,000 ($5.17) per dose.

Nanocovax vaccine (Photo: VNE)

One Vietnamese volunteer injected with Nanocovax (Photo: VNA)

Along with injections, Vietnam’s COVID-19 Nanocovax vaccine will also be developed in the form of eye-drop and nasal spray for special subjects.

Vietnam has four Covid-19 vaccines produced by Nanogen, Vabiotech, Polyvac and the Institute of Vaccines and Medical Biologicals (IVAC) currently under research.

Vabiotech, Polyvac are currently evaluating their vaccines on animals, having completed the laboratory-scale production process.

Made-in-Vietnam COVID-19 vaccine promises a bright prospect Nanogen Biopharmaceutical company is expected to end its Nanocovax vaccine’s human trials by February 2022, opening hope that Vietnamese people will be resonably vacinated against ...

Vietnam all geared up for COVID-19 vaccine trials The first 60 volunteers among the selected 200 will be injected with Nanocovax – Vietnam's first local-made COVID-19 vaccine approved for human trials, from Thursday.

Vietnam to roll out nasal spray and eye-drop COVID-19 vaccine Along with injections, Vietnam’s COVID-19 Nanocovax vaccine will also be developed in the form of eye-drop and nasal spray for special subjects.